ARCHIVES

NIH Defines Misconduct

This article is from The Cancer Letter archive.

Vol. 20 No. 47 | December 9, 1994

Download PDF Visit The Full Archive

Related Articles

McCormick President-Elect of AACR; Garber To Start Term As President

March 25, 2011

Mammary Cell/Hormone Report Abstracts From BCTF Meeting

January 16, 1976

Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment.

July 30, 2004

NCI To Expand SPORE Grants Program to Increase Translational Research Funding

October 22, 1999

Clinical Trials Approved By NCI CTEP Last Month

March 25, 2011

Suspect Chemical Include Castor Oil, Witchhazel; Details On 38 Picked For Long Term Tests

August 5, 1977